Health Care Costs Associated With Parent-Reported ADHD: A Longitudinal Australian Population-Based Study

J Atten Disord. 2017 Nov;21(13):1063-1072. doi: 10.1177/1087054713491494. Epub 2013 Jul 1.

Abstract

Objective: To examine the health care costs associated with ADHD within a nationally representative sample of children.

Method: Data were from Waves 1 to 3 (4-9 years) of the Longitudinal Study of Australian Children ( N = 4,983). ADHD was defined by previous diagnosis and a measure of ADHD symptoms (Strengths and Difficulties Questionnaire [SDQ]). Participant data were linked to administrative data on health care costs. Analyses controlled for demographic factors and internalizing and externalizing comorbidities.

Results: Costs associated with health care attendances and medications were higher for children with parent-reported ADHD at each age. Cost differences were highest at 8 to 9 years for both health care attendances and medications. Persistent symptoms were associated with higher costs ( p < .001). Excess population health care costs amounted to Aus$25 to Aus$30 million over 6 years, from 4 to 9 years of age.

Conclusion: ADHD is associated with significant health care costs from early in life. Understanding the costs associated with ADHD is an important first step in helping to plan for service-system changes.

Keywords: ADHD; children; costs; economic; health care; medication.

MeSH terms

  • Adult
  • Attention Deficit Disorder with Hyperactivity / economics*
  • Attention Deficit Disorder with Hyperactivity / epidemiology
  • Australia / epidemiology
  • Child
  • Child, Preschool
  • Comorbidity
  • Female
  • Health Care Costs*
  • Humans
  • Longitudinal Studies
  • Male
  • Parents*
  • Population Surveillance